Quarterly Newsletter

Happy New Year! Welcome to the winter edition of our quarterly newsletter. We are excited to share these highlights below to help you get the most out of your ImmPort experience.

What's New?   New Datasets   COVID-19 Studies   Cohort Discovery Tool
New Resource Page: SeroNet

Data Release - New ImmPort Data has Arrived!
 
ImmPort's latest data release contains over 15,000 measurements across 17 studies. Data types include ELISA, RNA sequencing, and more. Multiple research studies are available including COVID-19, malaria, preterm birth, and clinical trials data.
To view all studies associated with this release, see the Data Release 42 notes. As a reminder, all ImmPort datasets are freely available upon registration and can be queried and downloaded using either a web browser or RESTful APIs.
New Features and Resources Now Available
As researchers ourselves, we know time is precious. Being able to quickly identify data sets of interest is critical. ImmPort's new Cohort Discovery Tool aims to make finding data a breeze. We hope you'll take it for a test drive and drop us your feedback.
Also, be sure to visit the new SeroNet Resource Page. The Serological Sciences Network (SeroNet), is the nation's largest coordinated effort to study the immune response to COVID-19. Better yet, they are making their valuable data available through ImmPort.
 
Featured Publication: Application of Machine Learning
for Cytometry Data
Front. Immunol., 03 January 2022 https://doi.org/10.3389/fimmu.2021.78757
Zicheng Hu, Sanchita Bhattacharya, and Atul J. Butte
Machine learning techniques are well suited to analyze complex cytometry data and have been used in multiple facets of cytometry data analysis. Recently published in Frontiers in Immunology, Application of Machine Learning for Cytometry Data discusses existing machine learning applications for analyzing cytometry data and highlights the importance of publicly available cytometry data for researchers.
 
Register Now for the FOCiS Big Data in Immunology Workshop
ImmPort team members will once again lead an exciting workshop about big data in immunology as part of the FOCiS 2022 annual meeting. This workshop typically fills up fast, so be sure to register soon to grab your spot.
Share Your Data with ImmPort
Your data goes further when shared and can lead to innovative new discoveries.  Join your research colleagues in sharing data through the ImmPort platform.  ImmPort team members are happy to assist with data uploads.  Contact us ImmPort_Helpdesk@immport.org
ImmPort contains: 500+ studies and 78K subjects for 129 diseases supported by 1900 experiments, 6M test results, and 1.2M laboratory results
Follow us on Twitter Follow us on Twitter
Follow us on Facebook Follow us on Facebook
ImmPort is a recommended data repository by PLoS One and Nature's Scientific Data, and holds the Core Trust Seal of Approval for Core Trustworthy Data Repositories
Copyright © 2022 ImmPort, All rights reserved.
Our mailing address is:
ImmPort_Helpdesk@immport.org
No longer want to receive these emails?
unsubscribe from this list.
Were you forwarded this message? Subscribe here to receive our mailings
Forward Forward